43 results on '"De Bree, Remco"'
Search Results
2. What is the role of sentinel lymph node biopsy in the management of oral cancer in 2020?
- Author
-
de Bree, Remco, de Keizer, Bart, Civantos, Francisco J., Takes, Robert P., Rodrigo, Juan P., Hernandez-Prera, Juan C., Halmos, Gyorgy B., Rinaldo, Alessandra, and Ferlito, Alfio
- Published
- 2021
- Full Text
- View/download PDF
3. Depression and related factors after oral oncological treatment: a 5-year prospective cohort study
- Author
-
Speksnijder, Caroline M., Lankhorst, Petra J. M., de Bree, Remco, de Haan, Anton F. J., Koole, Ron, and Merkx, Matthias A. W.
- Published
- 2021
- Full Text
- View/download PDF
4. Sentinel lymph node detection in oral cancer: a within-patient comparison between [99mTc]Tc-tilmanocept and [99mTc]Tc-nanocolloid
- Author
-
den Toom, Inne J., Mahieu, Rutger, van Rooij, Rob, van Es, Robert J. J., Hobbelink, Monique G. G., Krijger, Gerard C., Tijink, Bernard M., de Keizer, Bart, and de Bree, Remco
- Published
- 2021
- Full Text
- View/download PDF
5. Feasibility of an MR-based digital specimen for tongue cancer resection specimens: a novel approach for margin evaluation.
- Author
-
de Koning, Klijs Jacob, Dankbaar, Jan Willem, de Keizer, Bart, Willemsen, Koen, van der Toorn, Annette, Breimer, Gerben Eise, van Es, Robert Jelle Johan, de Bree, Remco, Noorlag, Rob, and Petronella Philippens, Marielle Emile
- Subjects
TONGUE cancer ,ONCOLOGIC surgery ,SURGICAL margin ,SENSITIVITY & specificity (Statistics) ,MAGNETIC resonance ,GLOSSECTOMY - Abstract
Objective: This study explores the feasibility of ex-vivo high-field magnetic resonance (MR) imaging to create digital a three-dimensional (3D) representations of tongue cancer specimens, referred to as the "MR-based digital specimen" (MR-DS). The aim was to create a method to assist surgeons in identifying and localizing inadequate resection margins during surgery, a critical factor in achieving locoregional control. Methods: Fresh resection specimens of nine tongue cancer patients were imaged in a 7 Tesla small-bore MR, using a high-resolution multislice and 3D T2-weighted Turbo Spin Echo. Two independent radiologists (R1 and R2) outlined the tumor and mucosa on the MR-images whereafter the outlines were configured to an MR-DS. A color map was projected on the MR-DS, mapping the inadequate margins according to R1 and R2. We compared the hematoxylin-eosin-based digital specimen (HE-DS), which is a histopathological 3D representation derived from HE stained sections, with its corresponding MRimages. In line with conventional histopathological assessment, all digital specimens were divided into five anatomical regions (anterior, posterior, craniomedial, caudolateral and deep central). Over- and underestimation 95thpercentile Hausdorff-distances were calculated between the radiologist- and histopathologist-determined tumor outlines. The MR-DS' diagnostic accuracy for inadequate margin detection (i.e. sensitivity and specificity) was determined in two ways: with conventional histopathology and HE-DS as reference. Results: Using conventional histopathology as a reference, R1 achieved 77% sensitivity and 50% specificity, while R2 achieved 65% sensitivity and 57% specificity. When referencing to the HE-DS, R1 achieved 94% sensitivity and 61% specificity, while R2 achieved 88% sensitivity and 71% specificity. Range of over- and underestimation 95HD was 0.9 mm - 11.8 mm and 0.0 mm - 5.3 mm, respectively. Conclusion: This proof of concept for volumetric assessment of resection margins using MR-DSs, demonstrates promising potential for further development. Overall, sensitivity is higher than specificity for inadequate margin detection, because of the radiologist's tendency to overestimate tumor size. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. The added value of SPECT-CT for the identification of sentinel lymph nodes in early stage oral cancer
- Author
-
den Toom, Inne J., van Schie, Annelies, van Weert, Stijn, Karagozoglu, K. Hakki, Bloemena, Elisabeth, Hoekstra, Otto S., and de Bree, Remco
- Published
- 2017
- Full Text
- View/download PDF
7. Ultrasound‐guided resection for squamous cell carcinoma of the buccal mucosa: A feasibility study.
- Author
-
Adriaansens, Carleen M. E. M., de Koning, Klijs J., de Bree, Remco, Dankbaar, Jan Willem, Breimer, Gerben E., van Es, Robert J. J., and Noorlag, Rob
- Subjects
SQUAMOUS cell carcinoma ,COMPUTER-assisted surgery ,MUCOUS membranes ,SURGICAL margin ,FEASIBILITY studies ,URETHROPLASTY - Abstract
Background: Image‐guided surgery could help obtain clear (≥5.0 mm) resection margins. This feasibility study investigated ultrasound‐guided resection accuracy of buccal mucosa squamous cell carcinoma (BMSCC). Methods: MRI and ultrasound measurements of tumor thickness were compared to histology in 13 BMSCC‐patients. Ultrasound measured margins (at five locations) on the specimen were compared to the corresponding histological margins. Results: Accuracy of in‐ and ex‐vivo ultrasound (mean deviation from histology: 1.6 mm) for measuring tumor thickness was comparable to MRI (mean deviation from histology: 2.6 mm). The sensitivity to detect clear margins using ex‐vivo ultrasound was low (48%). If an ex‐vivo ultrasound cutoff of ≥7.5 mm would be used, the sensitivity would increase to 86%. Conclusions: Ultrasound‐guided resection of BMSCC's is feasible. In‐ and ex‐vivo ultrasound measure tumor thickness in BMSCC accurately. We recommend ≥7.5 mm resection margins on ex‐vivo ultrasound to obtain histological clear margins. Additional research is required to establish the effect of 7.5 mm ultrasound cutoff. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Sentinel lymph node biopsy in oral and oropharyngeal squamous cell carcinoma: current status and unresolved challenges
- Author
-
Bluemel, Christina, Rubello, Domenico, Colletti, Patrick M., de Bree, Remco, and Herrmann, Ken
- Published
- 2015
- Full Text
- View/download PDF
9. Head and neck cancer: towards a new paradigm with sentinel node localization
- Author
-
de Bree, Remco
- Published
- 2015
- Full Text
- View/download PDF
10. Practice variation in defining sentinel lymph nodes on lymphoscintigrams in oral cancer patients
- Author
-
Flach, Géke B., van Schie, Annelies, Witte, Birgit I., Olmos, Renato A. Valdés, Klop, W. Martin C., Hoekstra, Otto S., and de Bree, Remco
- Published
- 2014
- Full Text
- View/download PDF
11. CT Lymphography Using Lipiodol ® for Sentinel Lymph Node Biopsy in Early-Stage Oral Cancer.
- Author
-
Mahieu, Rutger, Donders, Dominique N. V., Dankbaar, Jan Willem, de Bree, Remco, and de Keizer, Bart
- Subjects
SENTINEL lymph node biopsy ,LYMPHANGIOGRAPHY ,ORAL cancer ,SENTINEL lymph nodes ,COMPUTED tomography - Abstract
This study evaluated sentinel lymph node (SLN) identification with CT lymphography (CTL) following peritumoral administration of Lipiodol
® relative to conventional99m Tc-nanocolloid lymphoscintigraphy (including SPECT/CT) in 10 early-stage oral cancer patients undergoing SLN biopsy. Patients first underwent early dynamic and static scintigraphy after peritumoral administration of99m Tc-nanocolloid. Subsequently, Lipiodol® was administered at the same injection sites, followed by fluoroscopy and CT acquisition. Finally, late scintigraphy and SPECT/CT were conducted, enabling the fusion of late CTL and SPECT imaging. The next day, designated SLNs were harvested, radiographically examined for Lipiodol® uptake and histopathologically assessed. Corresponding images of CT,99m Tc-nanocolloid lymphoscintigraphy and SPECT/late CTL fusion were evaluated.99m Tc-nanocolloid lymphoscintigraphy identified 21 SLNs, of which 7 were identified with CTL (33%). CTL identified no additional SLNs and failed to identify any SLNs in four patients (40%). Out of six histopathologically positive SLNs, two were identified by CTL (33%). Radiographic examination confirmed Lipiodol® uptake in seven harvested SLNs (24%), of which five were depicted by CTL. CTL using Lipiodol® reached a sensitivity of 50% and a negative predictive value (NPV) of 75% (median follow-up: 12.3 months). These results suggest that CTL using Lipiodol® is not a reliable technique for SLN mapping in early-stage oral cancer. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
12. Within-patient comparison between [68Ga]Ga-tilmanocept PET/CT lymphoscintigraphy and [99mTc]Tc-tilmanocept lymphoscintigraphy for sentinel lymph node detection in oral cancer: a pilot study.
- Author
-
Mahieu, Rutger, Donders, Dominique N. V., Krijger, Gerard C., Ververs, F. F. Tessa, de Roos, Remmert, Bemelmans, John L. M. M., van Rooij, Rob, de Bree, Remco, and de Keizer, Bart
- Subjects
SENTINEL lymph nodes ,ORAL cancer ,EMISSION-computed tomography ,COMPUTED tomography ,LYMPHATICS - Abstract
Purpose: To compare sentinel lymph node (SLN) identification using [
68 Ga]Ga-tilmanocept PET/CT lymphoscintigraphy to [99m Tc]Tc-tilmanocept lymphoscintigraphy (including SPECT/CT) in early-stage oral cancer. Furthermore, to assess whether reliable intraoperative SLN localization can be performed with a conventional portable gamma-probe using [99m Tc]Tc-tilmanocept without the interference of [68 Ga]Ga-tilmanocept in these patients. Methods: This prospective within-patient comparison pilot study evaluated SLN identification by [68 Ga]Ga-tilmanocept PET/CT lymphoscintigraphy compared to conventional lymphoscintigraphy using [99m Tc]Tc-tilmanocept (~ 74 MBq) in 10 early-stage oral cancer patients scheduled for SLN biopsy. After conventional [99m Tc]Tc-tilmanocept lymphoscintigraphy, patients underwent peritumoral administration of [68 Ga]Ga-tilmanocept (~ 10 MBq) followed by PET/CT acquisition initiated 15 min after injection. Intraoperative SLN localization was performed under conventional portable gamma-probe guidance the next day; the location of harvested SLNs was correlated to both lymphoscintigraphic images in each patient. Results: A total of 24 SLNs were identified by [99m Tc]Tc-tilmanocept lymphoscintigraphy, all except one were also identified by [68 Ga]Ga-tilmanocept PET/CT lymphoscintigraphy. [68 Ga]Ga-tilmanocept PET/CT lymphoscintigraphy identified 4 additional SLNs near the injection site, of which two harbored metastases. Lymphatic vessels transporting [68 Ga]Ga-tilmanocept were identified by PET/CT lymphoscintigraphy in 80% of patients, while draining lymphatic vessels were visualized by [99m Tc]Tc-tilmanocept lymphoscintigraphy in 20% of patients. Of the 33 SLNs identified by [68 Ga]Ga-tilmanocept PET/CT lymphoscintigraphy, 30 (91%) were intraoperatively localized under conventional gamma-probe guidance. Conclusion: [68 Ga]Ga-tilmanocept PET/CT lymphoscintigraphy provided more accurate identification of SLNs and improved visualization of lymphatic vessels compared to [99m Tc]Tc-tilmanocept lymphoscintigraphy. When combined with peritumoral administration of [99m Tc]Tc-tilmanocept, SLNs detected by [68 Ga]Ga-tilmanocept PET/CT lymphoscintigraphy can be reliably localized during surgery under conventional gamma-probe guidance. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
13. Diagnostic accuracy of [99mTc]Tc‐tilmanocept compared to [99mTc]Tc‐nanocolloid for sentinel lymph node identification in early‐stage oral cancer.
- Author
-
Mahieu, Rutger, den Toom, Inne J., van Rooij, Rob, van Es, Robert J. J., Hobbelink, Monique G. G., Krijger, Gerard C., Tijink, Bernard M., de Keizer, Bart, and de Bree, Remco
- Subjects
NECK dissection ,SENTINEL lymph nodes ,TONGUE cancer ,HEAD & neck cancer ,ORAL cancer ,SENTINEL lymph node biopsy - Abstract
Keywords: [99mTc]Tc-tilmanocept; Lymph Node; Lymphoscintigraphy; metastasis; oral cancer; sentinel lymph node biopsy EN [99mTc]Tc-tilmanocept Lymph Node Lymphoscintigraphy metastasis oral cancer sentinel lymph node biopsy 1383 1388 6 10/14/21 20211101 NES 211101 KEY POINTS This study compares sentinel lymph node identification using [ SP 99m sp Tc]Tc-tilmanocept to [ SP 99m sp Tc]Tc-nanocolloid in early-stage oral cancer patients. Diagnostic accuracy of [
99m Tc]Tc-tilmanocept compared to [99m Tc]Tc-nanocolloid for sentinel lymph node identification in early-stage oral cancer The prospective cohort has been described in the prequel study in detail.4 Patients underwent lymphoscintigraphy including SPECT-CT for both [ SP 99m sp Tc]Tc-tilmanocept and [ SP 99m sp Tc]Tc-nanocolloid. Besides, owing to relatively low activity residing in SLNs for [ SP 99m sp Tc]Tc-tilmanocept, intraoperative SLN localisation was challenging in some patients when using [ SP 99m sp Tc]Tc-tilmanocept for SLNB. [Extracted from the article]- Published
- 2021
- Full Text
- View/download PDF
14. Comparison of different diagnostic approaches in the management of the clinically negative neck in early oral cancer patients.
- Author
-
Bree, Remco, Keizer, Bart, de Bree, Remco, and de Keizer, Bart
- Subjects
ORAL cancer ,CANCER patients ,SENTINEL lymph nodes ,POSITRON emission tomography ,COST effectiveness - Abstract
In clinically node‐negative patients with early oral cavity cancer, [18F]fludeoxyglucose (FDG) positron emission tomography–computed tomography (PET‐CT) should be compared with sentinel node biopsy. Cost effectiveness is one of the important aspects for implementation of FDG/PET‐CT in clinical practice for this patient population. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
15. Contralateral Regional Recurrence in Lateralized or Paramedian Early-Stage Oral Cancer Undergoing Sentinel Lymph Node Biopsy—Comparison to a Historic Elective Neck Dissection Cohort.
- Author
-
Mahieu, Rutger, den Toom, Inne J., Boeve, Koos, Lobeek, Daphne, Bloemena, Elisabeth, Donswijk, Maarten L., de Keizer, Bart, Klop, W. Martin C., Leemans, C. René, Willems, Stefan M., Takes, Robert P., Witjes, Max J. H., and de Bree, Remco
- Subjects
SENTINEL lymph node biopsy ,CANCER relapse ,NECK dissection ,ORAL cancer ,CANCER genetics ,SQUAMOUS cell carcinoma - Abstract
Introduction: Nowadays, two strategies are available for the management of the clinically negative neck in early-stage (cT1-2N0) oral squamous cell carcinoma (OSCC): elective neck dissection (END) and sentinel lymph node biopsy (SLNB). SLNB stages both the ipsilateral and the contralateral neck in early-stage OSCC patients, whereas the contralateral neck is generally not addressed by END in early-stage OSCC not involving the midline. This study compares both incidence and hazard of contralateral regional recurrences (CRR) in those patients who underwent END or SLNB. Materials and Methods: A retrospective multicenter cohort study, including 816 lateralized or paramedian early-stage OSCC patients, staged by either unilateral or bilateral END (n = 365) or SLNB (n = 451). Results: The overall rate of occult contralateral nodal metastasis was 3.7% (30/816); the incidence of CRR was 2.5% (20/816). Patients who underwent END developed CRR during follow-up more often than those who underwent SLNB (3.8 vs. 1.3%; p = 0.018). Moreover, END patients had a higher hazard for developing CRR than SLNB patients (HR = 2.585; p = 0.030). In addition, tumor depth of invasion was predictive for developing CRR (HR = 1.922; p = 0.009). Five-year disease-specific survival in patients with CRR was poor (42%) compared to patients in whom occult contralateral nodal metastases were detected by SLNB or bilateral END (88%), although not statistically different (p = 0.066). Conclusion: Our data suggest that SLNB allows for better control of the contralateral clinically negative neck in patients with lateralized or paramedian early-stage OSCC, compared to END as performed in a clinical setting. The prognosis of those in whom occult contralateral nodal metastases are detected at an earlier stage may be favorable compared to those who eventually develop CRR, which highlights the importance of adequate staging of the contralateral clinically negative neck. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
16. Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures.
- Author
-
Mes, Steven W., van Velden, Floris H. P., Peltenburg, Boris, Peeters, Carel F. W., te Beest, Dennis E., van de Wiel, Mark A., Mekke, Joost, Mulder, Doriene C., Martens, Roland M., Castelijns, Jonas A., Pameijer, Frank A., de Bree, Remco, Boellaard, Ronald, Leemans, C. René, Brakenhoff, Ruud H., and de Graaf, Pim
- Subjects
SQUAMOUS cell carcinoma ,OROPHARYNGEAL cancer ,FORECASTING ,MOUTH ,ORAL cancer ,HEAD & neck cancer - Abstract
Objectives: Head and neck squamous cell carcinoma (HNSCC) shows a remarkable heterogeneity between tumors, which may be captured by a variety of quantitative features extracted from diagnostic images, termed radiomics. The aim of this study was to develop and validate MRI-based radiomic prognostic models in oral and oropharyngeal cancer. Materials and Methods: Native T1-weighted images of four independent, retrospective (2005–2013), patient cohorts (n = 102, n = 76, n = 89, and n = 56) were used to delineate primary tumors, and to extract 545 quantitative features from. Subsequently, redundancy filtering and factor analysis were performed to handle collinearity in the data. Next, radiomic prognostic models were trained and validated to predict overall survival (OS) and relapse-free survival (RFS). Radiomic features were compared to and combined with prognostic models based on standard clinical parameters. Performance was assessed by integrated area under the curve (iAUC). Results: In oral cancer, the radiomic model showed an iAUC of 0.69 (OS) and 0.70 (RFS) in the validation cohort, whereas the iAUC in the oropharyngeal cancer validation cohort was 0.71 (OS) and 0.74 (RFS). By integration of radiomic and clinical variables, the most accurate models were defined (iAUC oral cavity, 0.72 (OS) and 0.74 (RFS); iAUC oropharynx, 0.81 (OS) and 0.78 (RFS)), and these combined models outperformed prognostic models based on standard clinical variables only (p < 0.001). Conclusions: MRI radiomics is feasible in HNSCC despite the known variability in MRI vendors and acquisition protocols, and radiomic features added information to prognostic models based on clinical parameters. Key Points: • MRI radiomics can predict overall survival and relapse-free survival in oral and HPV-negative oropharyngeal cancer. • MRI radiomics provides additional prognostic information to known clinical variables, with the best performance of the combined models. • Variation in MRI vendors and acquisition protocols did not influence performance of radiomic prognostic models. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
17. Cytokeratin 19 expression in early oral squamous cell carcinoma and their metastasis : Inadequate biomarker for one-step nucleic acid amplification implementation in sentinel lymph node biopsy procedure
- Author
-
Noorlag, Rob, van Es, Robert J J, de Bree, Remco, and Willems, Stefan M
- Subjects
sentinel lymph node biopsy (SLNB) ,stomatognathic diseases ,one-step nucleic acid amplification ,Journal Article ,oral cancer ,cytokeratin 19 - Abstract
BACKGROUND: Intraoperative analysis of lymph nodes during a sentinel lymph node biopsy (SLNB) procedure could result in one-step surgery for early oral squamous cell carcinoma (OSCC) with an occult nodal metastasis. One-step nucleic acid amplification rapidly detects cytokeratin 19 (CK19) RNA with high accuracy. Sensitivity and specificity of CK19 expression in OSCC was evaluated. METHODS: Immunohistochemical CK19 expression was done in 207 patients with OSCC with 65 cases of paired nodal metastases. RESULTS: CK19 was expressed in 65% of all OSCC and even less in early OSCC (56%), with poor correlation between primary tumor and (occult) nodal metastasis. Furthermore, ectopic glandular tissue in close proximity of lymph nodes showed strong CK19 expression. CONCLUSION: CK19 lacks both sensitivity and specificity as a biomarker for nodal metastasis in OSCC, which questions the suitability for CK19-based one-step nucleic acid amplification in SLNB procedures. Therefore, future studies should focus on other biomarkers, because the concept of fast intraoperative diagnostics during SLNB remains attractive.
- Published
- 2017
18. Sentinel node biopsy for early-stage oral cavity cancer : The VU University Medical Center experience
- Author
-
Den Toom, Inne J., Heuveling, Derrek A., Flach, Géke B., Van Weert, Stijn, Karagozoglu, K. Hakki, Van Schie, Annelies, Bloemena, Elisabeth, Leemans, C. René, and De Bree, Remco
- Subjects
squamous cell carcinoma ,lymph node metastasis ,Otorhinolaryngology ,oral cancer ,sentinel node biopsy - Abstract
Background Sentinel node biopsy (SNB) in head and neck cancer is recently introduced as the staging technique of oral squamous cell carcinoma. We report the results of SNB in patients diagnosed with a T1-T2 oral squamous cell carcinoma and clinically negative (N0) neck in a single center. Methods A retrospective analysis of 90 previously untreated patients who underwent SNB between 2007 and 2012 was performed. The SNB procedure consisted of preoperatively performed lymphoscintigraphy, intraoperative detection using blue dye, and gamma probe guidance and histopathologic examination including step-serial sectioning (SSS) and immunohistochemical (IHC) staining. A positive SNB was followed by neck dissection, whereas regular follow-up with ultrasound-guided fine-needle aspiration cytology (FNAC) was done in case of a negative SNB. Results The lymphoscintigraphic identification rate was 98% (88 of 90 patients) and the surgical detection rate was 99% (87 of 88 patients). The upstaging rate was 30%. Sensitivity of SNB was 93% and the negative predictive value was 97%. The median follow-up was 18 months (range, 2-62 months). Overall survival (OS) and disease-free survival (DFS) for SNB negative were 100% and 84% and for SNB positive patients 73% and 88%, respectively. Conclusion SNB is a reliable diagnostic staging technique for the clinically negative neck in patients with early-stage (T1-T2, cN0) oral squamous cell carcinoma.
- Published
- 2015
19. Elective neck dissection in oral squamous cell carcinoma: Past, present and future.
- Author
-
de Bree, Remco, Takes, Robert P., Shah, Jatin P., Hamoir, Marc, Kowalski, Luiz P., Robbins, K. Thomas, Rodrigo, Juan P., Sanabria, Alvaro, Medina, Jesus E., Rinaldo, Alessandra, Shaha, Ashok R., Silver, Carl, Suárez, Carlos, Bernal-Sprekelsen, Manuel, and Ferlito, Alfio
- Subjects
- *
DECISION support systems , *SQUAMOUS cell carcinoma , *NECK dissection , *DECISION making , *PHYSICIAN practice patterns , *METASTASIS , *MOUTH tumors , *NECK surgery , *PATIENT satisfaction , *PROGNOSIS , *QUALITY of life , *SHOULDER pain , *ELECTIVE surgery - Abstract
In 1994 a decision analysis, based on the literature and utility ratings for outcome by a panel of experienced head and neck physicians, was presented which showed a threshold probability of occult metastases of 20% to recommend elective treatment of the neck. It was stated that recommendations for the management of the cN0 neck are not immutable and should be reconfigured to determine the optimal management based on different sets of underlying assumptions. Although much has changed and is published in the almost 25 years after its publication, up to date this figure is still mentioned in the context of decisions on treatment of the clinically negative (cN0) neck. Therefore, we critically reviewed the developments in diagnostics and therapy and modeling approaches in the context of decisions on treatment of the cN0 neck. However, the results of studies on treatment of the cN0 neck cannot be translated to other settings due to significant differences in relevant variables such as population, culture, diagnostic work-up, follow-up, costs, institutional preferences and other factors. Moreover, patients may have personal preferences and may weigh oncologic outcomes versus morbidity and quality of life differently. Therefore, instead of trying to establish "the" best strategy for the cN0 neck or "the" optimal cut-off point for elective neck treatment, the approach to optimize the management of the cN0 neck would be to develop and implement models and decision support systems that can serve to optimize choices depending on individual, institutional, population and other relevant variables. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
20. The history of sentinel node biopsy in head and neck cancer: From visualization of lymphatic vessels to sentinel nodes.
- Author
-
de Bree, Remco and Nieweg, Omgo E.
- Subjects
- *
HEAD & neck cancer treatment , *HEAD & neck cancer patients , *SENTINEL lymph nodes , *BIOPSY , *LYMPHATICS - Abstract
Summary The aim of this report is to describe the history of sentinel node biopsy in head and neck cancer. Sentinel node biopsy is a minimally invasive technique to select patients for treatment of metastatic lymph nodes in the neck. Although this procedure has only recently been accepted for early oral cancer, the first studies on visualization of the cervical lymphatic vessels were reported in the 1960s. In the 1980s mapping of lymphatic drainage from specific head and neck sites was introduced. Sentinel node biopsy was further developed in the 1990s and after validation in this century the procedure is routinely performed in early oral cancer in several head and neck centers. New techniques may improve the accuracy of sentinel node biopsy further, particularly in difficult subsites like the floor of mouth. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
21. Surgical margins in the resection of oral squamous cell carcinoma under local versus general anesthesia.
- Author
-
van Munster, Meeke H., de Bree, Remco, Breimer, Gerben E., and Van Cann, Ellen M.
- Subjects
- *
SURGICAL margin , *SURGICAL excision , *SQUAMOUS cell carcinoma , *GENERAL anesthesia , *LOCAL anesthesia , *SOFT palate , *TONGUE cancer , *MOUTH tumors , *HEAD & neck cancer , *CANCER relapse , *RETROSPECTIVE studies ,TUMOR surgery - Abstract
Objectives: This study analyzes the influence of the surgical setting, i.e. resection under local anesthesia versus resection under general anesthesia, on surgical margins in tumor resection of stage I and II oral squamous cell carcinoma (OSCC).Materials and Methods: Retrospective study on tumor resections of stage I or II OSCC performed between 2014 and 2020. Potential predictors associated with surgical margins were identified. Multinomial logistic regression was used to analyze the effect of type of anesthesia on surgical margins, adjusted for potential predictors.Results: In total, 109 cases were included: 54 tumor resections were performed under local anesthesia and 55 under general anesthesia. Histopathological examination showed 19 clear surgical margins, 54 close surgical margins, and 36 positive surgical margins. Compared to resection under general anesthesia, resection under local anesthesia increased the risk of close margins (adjusted OR = 6.26; 95 %CI 1.66-23.58; p = .01) and positive margins (adjusted OR = 6.81; 95 %Cl 1.70-27.27; p = .01). Tumor resection of the floor of mouth, buccal mucosa, gingiva, retromolar trigone, hard palate, and soft palate had a higher risk of close and positive margins than tumor resection of the tongue. Tumor resection of the tongue under local anesthesia was associated with an increased risk of positive margins compared to resection under general anesthesia.Conclusion: Tumor resection under local anesthesia of stage I and II OSCC increases the risk of close and positive surgical margins compared to tumor resection under general anesthesia. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
22. Implications of a positive sentinel node in oral squamous cell carcinoma.
- Author
-
Gurney, Benjamin A. S., Schilling, Clare, Putcha, Venkata, Alkureishi, Lee W., Alvarez, Amezaga J., Bakholdt, Vivi, Barbier Herrero, Luis, Barzan, Luigi, Bilde, Anders, Bloemena, Elisabeth, Salces, Carmen Camarero, Palma, Paolo Dalla, de Bree, Remco, Dequanter, Didier, Dolivet, Gilles, Donner, Davide, Flach, Geke B., Fresno, Manuel, Grandi, Cesare, and Haerle, Stephan
- Subjects
SENTINEL lymph nodes ,SQUAMOUS cell carcinoma ,HEAD & neck cancer ,DISEASE management ,CANCER patient medical care ,HEALTH services administration ,CANCER ,PROGNOSIS ,CANCER risk factors - Abstract
Background The role of sentinel node biopsy in head and neck cancer is currently being explored. Patients with positive sentinel nodes were investigated to establish if additional metastases were present in the neck, their distribution, and their impact on outcome. Methods In all, 109 patients ( n = 109) from 15 European centers, with cT1/2,N0 tumors, and a positive sentinel lymph node were identified. Kaplan-Meier and univariate and multivariate logistic regression analysis were used to identify variables that predicted for additional positive nodes and their position within the neck. Results A total of 122 neck dissections were performed in 109 patients. Additional positive nodes were found in 34.4% of cases (42/122: 18 same, 21 adjacent, and 3 nonadjacent neck level). Additional nodes, especially if outside the sentinel node basin, had an impact on outcome. Conclusions The results are preliminary but suggest that both the number and the position of positive sentinel nodes may identify different prognostic groups that may allow further tailoring of management plans. © 2012 Wiley Periodicals, Inc. Head Neck, 2012 [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
23. Refinement of selection criteria to perform ultrasound guided aspiration cytology during follow-up in patients with early staged oral cavity carcinoma and initially cN0 necks
- Author
-
Rodjan, Firazia, de Bree, Remco, Weijs, Jelmer, Knol, Dirk L., Leemans, C. René, and Castelijns, Jonas A.
- Subjects
- *
ORAL cancer diagnosis , *CYTOLOGY , *FOLLOW-up studies (Medicine) , *LYMPH nodes , *RETROSPECTIVE studies , *HEAD & neck cancer , *MAGNETIC resonance imaging of cancer - Abstract
Summary: Currently, selection of lymph nodes for ultrasound-guided-fine-needle-aspiration cytology (USgFNAC) in patients with HNSCC relies mainly on size of lymph nodes. This retrospective study was undertaken to assess the potential value of size, laterality, level and changes in size as criteria for selection of nodes that need to be aspirated during follow-up of patients. We aim to reduce the number of unnecessary aspirations being performed without decreasing accuracy of USgFNAC. Eighty-one patients with oral cavity carcinoma (OCC) were eligible for observation-policy regarding treatment of the neck and received transoral excision of OCC. Selection of nodes for fine-needle-aspiration-cytology (FNAC) was based on size criterion. Localization (side and level) and size of aspirated lymph nodes were scored. Data on treatment and follow-up were collected and analyzed to assess the value of the used criteria. During follow-up all 17 positive nodes were found, of which 16 were ipsilateral. Contralateral metastasis was found in a patient with ipsilateral metastasis and a tumor crossing the midline. Minimal axial diameter (MAD) of all positive nodes was larger than 5.0mm in level II or 4.0mm in other levels. Follow-up aspirations in patients with OCC performed in the neck by USgFNAC can be reduced by 56% without increasing false-negative lymph nodes if follow-up aspirations would only be performed on the ipsilateral neck in lymph nodes with a MAD of 5mm in level II and 4mm in other levels or larger and in lymph nodes with rapid change of diameter. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
24. The potential role of non-FDG-PET in the management of head and neck cancer
- Author
-
Heuveling, Derrek A., de Bree, Remco, and van Dongen, Guus A.M.S.
- Subjects
- *
ORAL cancer , *HEAD & neck cancer , *SQUAMOUS cell carcinoma , *POSITRON emission tomography , *HYPOXEMIA , *MEDICAL imaging systems - Abstract
Summary: Positron emission tomography (PET) is a functional imaging modality that is widely used in oncology. The integration of PET with CT (PET–CT) provides at the same time also detailed morphological information, which is especially attractive for the anatomically complex head and neck region. The most widely used PET-tracer for imaging the enhanced metabolism of tumours is 18F-fluorodeoxyglucose (18FDG), but several new tracers for imaging of metabolic features other than glucose consumption (non-FDG tracers) have been developed with the aim to perform better than 18FDG in specific indications. For initial staging of head and neck squamous cell carcinoma (HNSCC) these tracers until now did not show a better performance than 18FDG. Most data suggest a potential role for non-FDG metabolic tracers for treatment response prediction and surveillance of HNSCC. This information may provide a guide for further individualized treatment decisions. The possibility of PET to image biologic features and molecular targets as key drivers of malignant growth and survival provides another important tool for treatment guidance. The presence of the biologic feature hypoxia, a common phenomenon in head and neck cancer, is associated with a poor response to (chemo) radiotherapy. Therefore, knowledge of hypoxia may influence treatment decisions. Several candidate hypoxia PET tracers are discussed. With the increasing knowledge of critical molecular targets in head and neck cancer (e.g. the epidermal growth factor receptor), many novel targeted anticancer therapeutics become available among which monoclonal antibodies and small molecular tyrosin kinase inhibitors. Upon labelling of these drugs with a positron emitter, their distribution within the human body can be quantitatively imaged by PET. In this way, PET can be used for better understanding of in vivo tumour biology, guidance of drug development, and appropriate treatment selection for the individual patient (personalized medicine). Altogether, the potential role of non-FDG-PET in the management of HNSCC seems to be guidance and surveillance of treatment of the individual patient. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
25. What is the role of sentinel lymph node biopsy in the management of oral cancer in 2010?
- Author
-
Civantos, Francisco J., Stoeckli, Sandro J., Takes, Robert P., Woolgar, Julia A., de Bree, Remco, Paleri, Vinidh, Devaney, Kenneth O., Rinaldo, Alessandra, Silver, Carl E., Mondin, Vanni, Werner, Jochen A., and Ferlito, Alfio
- Subjects
ORAL cancer ,SQUAMOUS cell carcinoma ,LYMPH nodes ,BIOPSY - Abstract
The article reflects on the role of sentinel lymph node biopsy in the management of oral cancer in 2010. It is said that oral squamous cell carcinoma (OSCC) is characterized by an anatomically stepwise progression of regional lymphatic metastases. It is also said that the need for a better diagnostic technique to identify subclinical cervical metastases and guide the treatment of patients has lead to the development of SLNB.
- Published
- 2010
- Full Text
- View/download PDF
26. Quality of life and functional status in patients with cancer of the oral cavity and oropharynx: pretreatment values of a prospective study.
- Author
-
Borggreven, Pepijn A., Verdonck-de Leeuw, Irma M., Muller, Martin J., Heiligers, Milou L. C. H., de Bree, Remco, Aaronson, Neil K., and Leemans, C. René
- Subjects
QUALITY of life ,ORAL cancer ,PHARYNGEAL diseases ,MICROCIRCULATION disorders ,COMORBIDITY ,OTOLARYNGOLOGY - Abstract
We assessed the pretreatment health-related quality of life (HRQOL) and functional status of patients with advanced oral and oropharyngeal cancer. Eighty patients were investigated. HRQOL was assessed by EORTC QLQ-C30/QLQ-H&N35 questionnaires. Functional status assessment comprised speech and oral function tests. The results revealed a wide range of HRQOL and functional deficits before treatment. HRQOL appeared to be related to some extent to tumor site (patients with oral tumors reported more pain compared to patients with oropharyngeal tumors) and tumor classification (patients with T3–T4 tumors reported more trouble opening the mouth and felt more ill compared to patients with T2 tumors). Comorbidity appeared to have a major impact. Patients with comorbidity had significantly worse scores on several scales/items on both the EORTC questionnaires. Functional deficits were related to tumor site, classification and comorbidity. Patients with oral cavity tumors (versus oropharyngeal tumors), patients with T3–T4 tumors (versus T2 tumors), and patients with comorbidity (versus without comorbidity) scored significantly worse on several speech and oral function tests. Impaired speech and oral function appeared to be clearly related to global quality of life (QLQ-C30) and self-reported speech (QLQ-H&N35). Many patients with advanced oral and oropharyngeal cancer have compromised HRQOL and functional status before the start of treatment. In addition to tumor site and tumor classification, comorbidity appears to have a major impact on HRQOL and functional status. Knowledge of pretreatment HRQOL and functional status levels is useful for better understanding the impact of treatment on these outcomes over time. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
27. Magnetic sentinel lymph node biopsy procedure in oral cancer.
- Author
-
Nieuwenhuis, Eliane, Kolenaar, Barry, Hof, Jurrit, Bemmel, Xander, Baarlen, Joop, Haken, Bennie ten, de Bree, Remco, and Alic, Lejla
- Subjects
SENTINEL lymph node biopsy ,SUPERPARAMAGNETIC materials ,ORAL cancer - Abstract
B Background: b Reliable identification of lymph node (LN) metastases is one of the most important prognostic factors to stratify the treatment in oral cancer (OC). This pilot study identifies LN metastases in OC patients using a magnetic approach for sentinel lymph node biopsy (SLNB) procedure. A total of 26 SLN were pathologically evaluated (8 LN in 0.4ml, and 18 in 0.8ml dose group), and yielded three patients with a metastatic LN (3/26 LN in total). [Extracted from the article]
- Published
- 2021
- Full Text
- View/download PDF
28. Second primary tumours in oral cancer
- Author
-
van der Waal, Isaäc and de Bree, Remco
- Subjects
- *
TREATMENT of oral cancer , *CANCER patients , *ALIMENTARY canal , *SMOKING cessation , *MEDICAL literature , *HEAD & neck cancer - Abstract
Summary: Second primary tumours in patients treated for oral cancer occur at a rate of 3% to 7% per year. The majority of these tumours show up at least six months after the detection of the primary and are often located in the upper aerodigestive tract. Cessation of smoking habits may reduce the risk of the development of a second primary. There is no statistical significance between the oral subsite of the primary and the occurence of a second primary. There are conflicting views in the literature on the survival rate of patients treated for a second primary in the head and neck region. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
29. Elective Neck Dissection or Sentinel Lymph Node Biopsy in Early Stage Oral Cavity Cancer Patients: The Dutch Experience.
- Author
-
den Toom, Inne J., Boeve, Koos, Lobeek, Daphne, Bloemena, Elisabeth, Donswijk, Maarten L., de Keizer, Bart, Klop, W. Martin C., Leemans, C. René, Willems, Stefan M., Takes, Robert P., Witjes, Max J.H., and de Bree, Remco
- Subjects
CANCER patients ,LONGITUDINAL method ,MEDICAL cooperation ,METASTASIS ,MOUTH tumors ,MOUTH floor ,NECK surgery ,RESEARCH ,TUMOR classification ,RETROSPECTIVE studies ,SENTINEL lymph node biopsy - Abstract
Background: Sentinel lymph node biopsy (SLNB) has been introduced as a diagnostic staging modality for detection of occult metastases in patients with early stage oral cancer. Comparisons regarding accuracy to the routinely used elective neck dissection (END) are lacking in literature. Methods: A retrospective, multicenter cohort study included 390 patients staged by END and 488 by SLNB. Results: The overall sensitivity (84% vs. 81%, p = 0.612) and negative predictive value (NPV) (93%, p = 1.000) were comparable between END and SLNB patients. The END cohort contained more pT2 tumours (51%) compared to the SLNB cohort (23%) (p < 0.001). No differences were found for sensitivity and NPV between SLNB and END divided by pT stage. In floor-of-mouth (FOM) tumours, SLNB had a lower sensitivity (63% vs. 92%, p = 0.006) and NPV (90% vs. 97%, p = 0.057) compared to END. Higher disease-specific survival (DSS) rates were found for pT1 SLNB patients compared to pT1 END patients (96% vs. 90%, p = 0.048). Conclusion: In the absence of randomized clinical trials, this study provides the highest available evidence that, in oral cancer, SLNB is as accurate as END in detecting occult lymph node metastases, except for floor-of-mouth tumours. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
30. Outcome of patients with early stage oral cancer managed by an observation strategy towards the N0 neck using ultrasound guided fine needle aspiration cytology: No survival difference as compared to elective neck dissection
- Author
-
Flach, Géke B., Tenhagen, Mark, de Bree, Remco, Brakenhoff, Ruud H., van der Waal, Isaac, Bloemena, Elisabeth, Kuik, Dirk J., Castelijns, Jonas A., and René Leemans, C.
- Subjects
- *
HEALTH outcome assessment , *TREATMENT of oral cancer , *CYTOLOGY , *ADJUVANT treatment of cancer , *LYMPHATIC metastasis , *COMPARATIVE studies , *DISSECTION , *SCIENTIFIC observation - Abstract
Summary: Objectives: Management of the clinically N0 neck in oral cancer patients remains controversial. We describe the outcome of patients with T1–T2 oral cancer and N0 neck based on ultrasound guided fine needle aspiration cytology (USgFNAC) who were treated by transoral excision and followed by a ‘wait and scan’ policy (W&S). Patients and methods: This retrospective analysis included 285 consecutive patients of whom 234 were followed by W&S and 51 underwent elective neck dissection (END). Survival rates were compared between groups and correction for confounding factors was performed. Results: Of W&S patients, the 5-year disease-specific (DSS) and overall survival (OS) were 94.2% and 81.6% respectively. During follow-up 72.2% remained free of lymph node metastases and 27.8% developed delayed metastases. W&S patients with delayed metastases had a 5-year DSS and OS of 80.0% and 62.8%, respectively. In patients with positive END these rates were 81.3% and 64.2%, respectively. Between the groups, survival rates were not significantly different. Of the W&S patients with delayed metastases, 90.6% needed adjuvant radiotherapy versus 55.0% of patients with positive END. Conclusion: With regard to survival, in patients with early stage oral cancer and cN0 neck a ‘wait and scan’ policy using strict USgFNAC surveillance is justified as survival is not negatively influenced. Using a ‘wait and scan’ follow-up strategy instead of elective neck treatment, unnecessary neck dissection and its accompanying morbidity can be avoided in 72.2% of patients. However, for the small proportion of patients with delayed metastases, more extensive treatment with adjuvant radiotherapy is needed. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
31. Feasibility study of ultrasound-guided resection of tongue cancer with immediate specimen examination to improve margin control - Comparison with conventional treatment.
- Author
-
de Koning, Klijs J., Koppes, Sjors A., de Bree, Remco, Dankbaar, Jan Willem, Willems, Stefan M., van Es, Robert J.J., and Noorlag, Rob
- Subjects
- *
TONGUE cancer , *SURGICAL margin , *ONCOLOGIC surgery , *FEASIBILITY studies , *HISTOPATHOLOGY ,TUMOR surgery - Abstract
Objectives: Squamous cell carcinoma of the tongue (SCCT) is preferably treated by surgery. Free resection margins (≥5 mm) provide local control and disease-free survival. However, close (1-5 mm) and positive margins (<1 mm) are frequently encountered. We present our first experience of in-vivo ultrasound (US) guided SCCT resections followed by ex-vivo US control on the resection specimen to obtain free margins. We compare the results with those from a hisorical cohort of 91 conventionally treated SCCT patients.Materials and Methods: Ten patients with SCCT were included in a consecutive US-cohort. We aimed for a 5-10 mm margin during surgery, while we visualized the resection plane on US. Ex-vivo US measurements on the resection specimen determined whether there was any need for an immediate re-resection. US measurements were then compared with histopathology. Histopathological margins were compared with a consecutive cohort of 91 patients who had undergone conventional surgery for a SCCT.Results: In the US cohort, 70% of the margins were free. In the conventional cohort, this figure was 17% (P = 0.005). US predicted minimal histopathological margin distance with a mean ± SD error of 1.9 ± 1.8 mm. The mean ± SD of the histopathological overall submucosal/deep margin distance was 7.9 ± 2.1 mm in the US cohort and 7.0 ± 2.2 mm in the conventional cohort (P = 0.188). Ex-vivo examination through use of US indicated an immediate re-resection, which prevented local adjuvant treatment.Conclusion: Use of US-guided SCCT resection is feasible and improves margin control. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
32. Differences in the association of time to treatment initiation and survival according to various head and neck cancer sites in a nationwide cohort.
- Author
-
Frank, Michaël H., van Dijk, Boukje A.C., Schoonbeek, Rosanne C., Zindler, Jaap, Devriese, Lot A., van Es, Robert J.J., Merkx, Matthias A.W., and de Bree, Remco
- Subjects
- *
HEAD & neck cancer , *HYPOPHARYNGEAL cancer , *LARYNGEAL cancer , *ORAL cancer , *OROPHARYNGEAL cancer - Abstract
• The relation between Time to Treatment Initiation (TTI) and overall survival was confirmed with variation among different sites. • Advanced stage oral cavity cancers had a significantly better hazard of dying when the TTI of 37 days was not exceeded. • Head and neck cancer sites are characterized by considerable heterogeneity. To assess whether there are differences in the effects of time to treatment interval (TTI) on patient survival for head and neck cancer (HNC) sites in order to provide evidence that can support decision-making regarding prioritizing treatment. Patients in the Netherlands with a first primary HNC without distant metastasis between 2010 and 2014 were included for analysis (N = 10,486). TTI was defined as the time from pathologic diagnosis to the start of initial treatment. Overall survival (OS), cox regression analyses and cubic spline hazard models were calculated and visualized. Overall, the hazard of dying was higher (HR = 1.003; 95 % CI 1.001–1.005) with each additional day until treatment initiation. The pattern, as visualized in cubic spline graphs, differed by site the hazard increased more steeply with increasing TTI for oral cavity cancer. For oropharyngeal and laryngeal cancer, a slight increase commenced after a longer TTI than for oral cavity cancer, while there was hardly an increase in hazard with increasing TTI for hypopharyngeal cancer. The relationship between longer TTI and decreased survival was confirmed, but slight variations in the pattern of the hazard of dying by TTI by tumour site were observed. These findings could support decisions on prioritizing treatment. However, other aspects such as extent of treatment and quality of life should be investigated further so this can also be included. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. High rate of unexpected lymphatic drainage patterns and a high accuracy of the sentinel lymph node biopsy in oral cancer after previous neck treatment.
- Author
-
den Toom, Inne J., Boeve, Koos, van Weert, Stijn, Bloemena, Elisabeth, Brouwers, Adrienne H., Hoekstra, Otto S., de Keizer, Bart, van der Vegt, Bert, Willems, Stefan M., Leemans, C. René, Witjes, Max J.H., and de Bree, Remco
- Subjects
- *
SENTINEL lymph node biopsy , *ORAL cancer , *NECK dissection , *THERAPEUTICS , *DRAINAGE , *HEAD & neck cancer , *HEAD tumors , *METASTASIS , *MOUTH tumors , *NECK tumors , *RETROSPECTIVE studies , *DISEASE complications - Abstract
Rationale: This study evaluates the lymphatic drainage patterns and determines the accuracy of the sentinel lymph node biopsy (SLNB) in patients diagnosed with a cT1-2N0 OSCC and a history of neck surgery or radiotherapy in three Dutch head and neck centers.Materials and Methods: Retrospective analysis of 53 cT1-2N0 OSCC patients, who underwent SLNB between 2007 and 2016, after a history of neck surgery or radiotherapy. Ten patients had previous treatment of the neck only contralateral from the current tumour. These ten patients were not used for the analysis of lymphatic drainage patterns. The 43 patients with previous ipsilateral or bilateral treatment of the neck had a history of ipsilateral SLN extirpation (n = 9; 21%), neck dissection (n = 16; 37%), radiotherapy (n = 10; 23%), or combined neck dissection and radiotherapy (n = 8; 19%).Results: SLNs were detected in 45 patients, resulting in an identification rate of 85% (45/53). Three patients (7%) had at least one positive SLN. One patient (1/45; 2%) was diagnosed with regional recurrence during the follow-up after a negative SLNB (sensitivity 75%, negative predictive value 98%). The first SLN was detected in level I-III in 58% of the patients, unexpected drainage patterns were observed in 30% (first SLN level IV 9% and level V 5% and contralateral neck in well-lateralized tumours 16%). In 12% no lymphatic drainage pattern was visible.Conclusions: SLNB seems to be a reliable procedure for neck staging of cT1-2N0 OSCC patients with a previously treated neck. SLNB determines the individual lymphatic drainage patterns, enabling visualization of unexpected drainage pattern variability in 30% of these patients. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
34. Surgical margins in head and neck cancer: Intra- and postoperative considerations.
- Author
-
Thomas Robbins, K., Triantafyllou, Asterios, Suárez, Carlos, López, Fernando, Hunt, Jennifer L., Strojan, Primož, Williams, Michelle D., Braakhuis, Boudewijn J.M., de Bree, Remco, Hinni, Michael L., Kowalski, Luiz P., Rinaldo, Alessandra, Rodrigo, Juan P., Vander Poorten, Vincent, Nixon, Iain J., Takes, Robert P., Silver, Carl E., and Ferlito, Alfio
- Subjects
- *
SURGICAL site , *HEAD & neck cancer , *TISSUE analysis , *FROZEN tissue sections , *MOLECULAR spectroscopy , *ORAL cancer , *ENDOSCOPY , *FLUORESCENCE spectroscopy , *HEAD tumors , *HISTOLOGICAL techniques , *MASS spectrometry , *NECK tumors , *RAMAN spectroscopy , *SPECTRUM analysis , *ULTRASONIC imaging , *OPTICAL coherence tomography , *RANDOMIZED controlled trials - Abstract
Objective: To provide a perspective on the significance of recent reports for optimizing cancer free surgical margins that have challenged standard practices.Methods: We conducted a review of the recent literature (2012-2018) using the keywords surgical margin analysis, frozen and paraffin section techniques, head and neck cancer, spectroscopy and molecular markers.Results: Of significance are the reports indicating superiority of tumor specimen directed sampling of margins compared to patient directed (tumor bed) sampling for frozen section control of oral cancers. With reference to optimal distance between tumor and the surgical margin, recent reports recommended cutoffs less than 5mm. Employment of new technologies such as light spectroscopy and molecular analysis of tissues, provide opportunities for a "real time" assessment of surgical margins.Conclusions: The commonly practiced method of patient directed margin sampling involving previous studies raises concern over conclusions made regarding the efficacy of frozen section margin control. The recent studies that challenge the optimal distance for clear surgical margins are retrospective and address patient cohorts with inherently confounding factors. The use of novel ancillary techniques require further refinements, clinical trial validation, and justification based on the additional resources. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
35. Intraoral ultrasonography to measure tumor thickness of oral cancer: A systematic review and meta-analysis.
- Author
-
Klein Nulent, Thomas J.W., Noorlag, Rob, Van Cann, Ellen M., Pameijer, Frank A., Willems, Stefan M., Yesuratnam, Adrian, Rosenberg, Antoine J.W.P., de Bree, Remco, and van Es, Robert J.J.
- Subjects
- *
TREATMENT of oral cancer , *ULTRASONIC imaging , *META-analysis , *TUMOR diagnosis , *THICKNESS measurement - Abstract
Early oral cancer is preferably treated by surgery. Its complete removal is essential for locoregional control and disease-free survival. Inadequate resection margins require adjuvant therapy such as re-resection or (chemo)radiation, that causes extra morbidity and oral discomfort. Intraoral ultrasonography (US) is reported to be of value in determining tumor thickness. Intraoperative visualization of the tumor may facilitate the resection and ensure adequate surgical margins. Furthermore, accurate prediction of tumor thickness could help determine the treatment strategy of the clinically node-negative neck, as thickness and depth of invasion are predictors of cervical metastasis as well as prognosticators of survival. The 8th edition of the American Joint Committee on Cancer staging system for oral squamous cell carcinoma has included depth of invasion as parameter for cT-stage. The aim of this review is to analyze the accuracy of intraoral US in determining tumor thickness in oral cancer. A systematic search was conducted, and the quality of the included papers was assessed using the QUADAS-2 tool for diagnostic accuracy studies. Subsequently, a meta-analysis was performed on the available individual participant data of 240 patients. Most of the twelve included studies focused on T1-2 tongue cancer (n = 129). Meta-analysis showed a high correlation in tumor thickness within this subgroup as measured by intraoral US and histopathology (r = 0.82, p < .001), with minor overestimation of 0.5 mm on US. It is concluded that intraoral US is very accurate in determining tumor thickness in early oral tongue cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
36. Application and accuracy of ultrasound-guided resections of tongue cancer.
- Author
-
de Koning, Klijs J., van Es, Robert J.J., Klijn, Reinoud J., Breimer, Gerben E., Willem Dankbaar, Jan, Braunius, Weibel W., van Cann, Ellen M., Dieleman, François J., Rijken, Johannes A., Tijink, Bernard M., de Bree, Remco, and Noorlag, Rob
- Abstract
Objectives: Surgical removal of squamous cell carcinoma of the tongue (SCCT) with tumour-free margin status (≥5 mm) is essential for loco-regional control. Inadequate margins (<5 mm) often indicate adjuvant treatment, which results in increased morbidity. Ultrasound (US)-guided SCCT resection may be a useful technique to achieve more adequate resection margins compared to conventional surgery. This study evaluates the application and accuracy of this technique.Methods: Forty patients with SCCT were included in a consecutive US cohort. During surgery, the surgeon aimed for a 10-mm echographic resection margin, while the tumour border and resection plane were captured in one image. Ex-vivo US measurements of the resection specimen determined whether there was a need for an immediate re-resection. The margin status and the administration of adjuvant treatment were compared those of with a consecutive cohort of 96 tongue cancer patients who had undergone conventional surgery. A receiver operating characteristic analysis was done to assess the optimal margin of ex-vivo US measurements to detect histopathologically inadequate margins.Results: In the US cohort, the frequency of free margin status was higher than in the conventional cohort (55% vs. 16%, p < 0.001), and the frequency of positive margins status (<1 mm) was lower (5% vs. 15%, respectively, p < 0.001). Adjuvant radiotherapy was halved (10% vs. 21%), and the need for re-resection was comparable (10% vs. 9%). A cut-off value of 8 mm for ex-vivo measurements prevented histopathologically inadequate margins in 76%.Conclusion: US-guided SCCT resections improve margin status and reduce the frequency of adjuvant radiotherapy. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
37. Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer.
- Author
-
Schilling, Clare, Stoeckli, Sandro J., Haerle, Stephan K., Broglie, Martina A., Huber, Gerhard F., Sorensen, Jens Ahm, Bakholdt, Vivi, Krogdahl, Annelise, von Buchwald, Christian, Bilde, Anders, Sebbesen, Lars R., Odell, Edward, Gurney, Benjamin, O'Doherty, Michael, de Bree, Remco, Bloemena, Elisabeth, Flach, Geke B., Villarreal, Pedro M., Fresno Forcelledo, Manuel Florentino, and Junquera Gutiérrez, Luis Manuel
- Subjects
- *
CANCER relapse , *LONGITUDINAL method , *MOUTH tumors , *NECK surgery , *SCIENTIFIC observation , *SQUAMOUS cell carcinoma , *TUMOR classification , *SALVAGE therapy , *SENTINEL lymph nodes , *DESCRIPTIVE statistics , *SENTINEL lymph node biopsy - Abstract
Purpose Optimum management of the N0 neck is unresolved in oral cancer. Sentinel node biopsy (SNB) can reliably detect microscopic lymph node metastasis. The object of this study was to establish whether the technique was both reliable in staging the N0 neck and a safe oncological procedure in patients with early-stage oral squamous cell carcinoma. Methods An European Organisation for Research and Treatment of Cancer-approved prospective, observational study commenced in 2005. Fourteen European centres recruited 415 patients with radiologically staged T1–T2N0 squamous cell carcinoma. SNB was undertaken with an average of 3.2 nodes removed per patient. Patients were excluded if the sentinel node (SN) could not be identified. A positive SN led to a neck dissection within 3 weeks. Analysis was performed at 3-year follow-up. Results An SN was found in 99.5% of cases. Positive SNs were found in 23% (94 in 415). A false-negative result occurred in 14% (15 in 109) of patients, of whom eight were subsequently rescued by salvage therapy. Recurrence after a positive SNB and subsequent neck dissection occurred in 22 patients, of which 16 (73%) were in the neck and just six patients were rescued. Only minor complications (3%) were reported following SNB. Disease-specific survival was 94%. The sensitivity of SNB was 86% and the negative predictive value 95%. Conclusion These data show that SNB is a reliable and safe oncological technique for staging the clinically N0 neck in patients with T1 and T2 oral cancer. EORTC Protocol 24021: Sentinel Node Biopsy in the Management of Oral and Oropharyngeal Squamous Cell Carcinoma. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
38. Evaluation of the use of freehand SPECT for sentinel node biopsy in early stage oral carcinoma.
- Author
-
Heuveling, Derrek A., van Weert, Stijn, Karagozoglu, K. Hakki, and de Bree, Remco
- Subjects
- *
SINGLE-photon emission computed tomography , *SENTINEL lymph node biopsy , *ORAL cancer diagnosis , *MEDICAL imaging systems , *THREE-dimensional imaging , *CANCER patients , *INTRAOPERATIVE monitoring - Abstract
Summary Rationale Inadequate intraoperative visualization of the sentinel node can hamper its harvest. Freehand SPECT is a 3D tomographic imaging modality based on the concepts of SPECT, which can be used for intraoperative visualization and navigation towards the sentinel node in order to improve its localization and removal during surgery. Patients and methods The use of freehand SPECT was evaluated during 66 sentinel node biopsy procedures in early stage oral cancer patients. Intraoperative detection of sentinel nodes was compared with preoperative identified sentinel nodes on lymphoscinitigraphic examination. Additional value of freehand SPECT was subjectively scored by the surgeon directly following the biopsy procedure. Results Freehand SPECT was able to detect 94% of sentinel nodes intraoperatively. Most sentinel nodes not detected (7 out of 9) were located in level I of the neck. Freehand SPECT appeared to be of additional value for facilitating the intraoperative detection of the sentinel node in 24% of procedures. Conclusion The use of the freehand SPECT system is feasible in the intraoperative detection of sentinel nodes in early stage oral cancer. Freehand SPECT provides helpful information facilitating the SN biopsy procedure in a quarter of cases. However, freehand SPECT cannot detect all SNs which are located in the vicinity of the injection site. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
39. Prospective evaluation of health-related quality of life in long-term oral and oropharyngeal cancer survivors and the perceived need for supportive care
- Author
-
Oskam, Inge M., Verdonck-de Leeuw, Irma M., Aaronson, Neil K., Witte, Birgit I., de Bree, Remco, Doornaert, Patricia, Langendijk, Johannes A., and René Leemans, C.
- Subjects
- *
QUALITY of life , *OROPHARYNGEAL cancer , *ORAL cancer , *PUBLIC health , *COMMUNICABLE diseases , *CANCER radiotherapy - Abstract
Summary: Purpose: To evaluate long-term changes in health related quality of life (HRQOL) in oral/oropharyngeal cancer survivors and their need for and use of supportive care. Methods: Between 1999 and 2001, 80 advanced oral or oropharyngeal cancer patients treated with free-flap reconstruction and postoperative radiotherapy were included in a prospective study of whom 27 patients were long-term survivors (mean 9.2years, range 8–11years). The HRQOL of 26 patients (response rate 96%) was assessed with the EORTC QLQ-C30 and QLQ-H&N35 questionnaires at four points in time: pretreatment (baseline), and at 6months, 12months (short term) and 8–11years (long-term) follow up. A study specific questionnaire was developed to evaluate the need for and use of supportive care (allied health services, peer contact, psychosocial care, and complementary care) and was completed at the period of treatment and at long-term follow up. Results: A number of HRQOL domains worsened significantly (p <0.01) in the long-term: emotional functioning, social functioning, swallowing, speech, taste/smell, dry mouth, sticky saliva and coughing assessed by the mixed effects statistical model. At time of treatment, the need for supportive care was the highest for a dental hygienist (77%), a physical therapist (73%), a speech therapist (42%), a dietician (38%), and a special diet (62%). At long-term follow up, the need for supportive care was limited to a dental hygienist (46%) and a physical therapist (23%). Only small differences were observed between the perceived need for and actual use of supportive care. Conclusion: A range of HRQOL domains in head and neck cancer survivors were deteriorated in the long-term compared to baseline and to the first year after treatment. At time of treatment and less frequently at long-term follow up, patients reported needing and using a variety of supportive care services. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
40. Sentinel node biopsy for oral and oropharyngeal squamous cell carcinoma in the previously treated neck
- Author
-
Flach, Géke B., Broglie, Martina A., van Schie, Annelies, Bloemena, Elisabeth, René Leemans, C., de Bree, Remco, and Stoeckli, Sandro J.
- Subjects
- *
SQUAMOUS cell carcinoma , *SENTINEL lymph nodes , *BIOPSY , *PHARYNGEAL cancer , *ORAL cancer , *CANCER radiotherapy , *ONCOLOGIC surgery , *HEAD & neck cancer treatment - Abstract
Summary: In patients with early stage oral or oropharyngeal squamous cell carcinoma (OSCC) sentinel node biopsy (SNB) is a reliable method to detect occult disease in the neck. However, patients with a history of surgery or radiotherapy in the neck may have aberrant lymphatic drainage caused by disruption of lymphatic channels. Therefore, treatment of the same levels at risk as in the primary setting may not be appropriate. The aim of our prospective observational study was to evaluate the clinical application of SNB in previously treated OSCC. Between 2003 and 2010 twenty-two patients were included. Lymph node mapping consisted of preoperative lymphoscintigraphy, SPECT/CT, intraoperative use of gamma-probe and patent blue. Endpoints were the sentinel node (SN) detection rate, unexpected lymphatic drainage patterns, negative predictive value and regional tumor control. 4/22 (18%) Patients were previously treated only on the contralateral site. The SN detection rate was 100% and unexpected drainage was found in 1/4 patients. The other 18 patients had ipsi- or bilateral previous neck treatment and a SN detection rate of 83%. The upstaging rate was 7% and 67% had unexpected lymphatic drainage patterns. The median follow-up was 22months. Regional tumor control and negative predictive value were 100%. SNB in previously treated OSCC patients is feasible. SN detection is reliable and regional tumor control after staging by SNB is excellent. Moreover, SNB renders an assessment of the individual lymphatic drainage pattern, compensating for a potential variability after previous treatment of the neck. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
41. A complete magnetic sentinel lymph node biopsy procedure in oral cancer patients: A pilot study.
- Author
-
Nieuwenhuis, Eliane R., Kolenaar, Barry, van Bemmel, Alexander J.M., Hof, Jurrit J., van Baarlen, Joop, Christenhusz, Anke, Pouw, Joost J., ten Haken, Bernard, Alic, Lejla, and de Bree, Remco
- Subjects
- *
SENTINEL lymph node biopsy , *SUPERPARAMAGNETIC materials , *ORAL cancer , *CANCER patients , *IRON oxide nanoparticles , *IRON ores - Abstract
Objectives: To assess the feasibility and merits of a complete magnetic approach for a sentinel lymph node biopsy (SLNB) procedure in oral cancer patients.Materials and Methods: This study included ten oral cancer patients (stage cT1-T2N0M0) scheduled for elective neck dissection (END). Superparamagnetic iron oxide nanoparticles (SPIO) were administered peritumorally prior to surgery. A preoperative MRI was acquired to identify lymph nodes (LNs) with iron uptake. A magnetic detector was used to identify magnetic hotspots prior, during, and after the SLNB procedure. The resected sentinel LNs (SLNs) were evaluated using step-serial sectioning, and the neck dissection specimen was assessed by routine histopathological examination. A postoperative MRI was acquired to observe any residual iron.Results: Of ten primary tumors, eight were located in the tongue, one floor-of-mouth (FOM), and one tongue-FOM transition. SPIO injections were experienced as painful by nine patients, two of whom developed a tongue swelling. In eight patients, magnetic SLNs were successfully detected and excised during the magnetic SLNB procedure. During the END procedure, additional magnetic SLNs were identified in three patients. Histopathology confirmed iron deposits in sinuses of excised SLNs. Three SLNs were harboring metastases, of which one was identified only during the END procedure. The END specimens revealed no further metastases.Conclusion: A complete magnetic SLNB procedure was successfully performed in eight of ten patients (80% success rate), therefore the procedure seems feasible. Recommendations for further investigation are made including: use of anesthetics, magnetic tracer volume, planning preoperative MRI, comparison to conventional technique and follow-up. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
42. Assessment of tumour depth in early tongue cancer: Accuracy of MRI and intraoral ultrasound.
- Author
-
Noorlag, Rob, Klein Nulent, Thomas J.W., Delwel, Valerie E.J., Pameijer, Frank A., Willems, Stefan M., de Bree, Remco, and van Es, Robert J.J.
- Subjects
- *
TONGUE cancer , *GLOSSECTOMY , *TUMORS , *MAGNETIC resonance imaging , *ESTIMATION theory - Abstract
Objectives: Complete resection of tongue cancer is necessary to achieve local control. Unfortunately, deep resection margins are frequently inadequate. To improve deep margin control, accurate knowledge of tumour thickness is pivotal. Magnetic resonance imaging (MRI) and intraoral ultrasound (ioUS) are frequently applied for tumour staging. This study explores the accuracy of these techniques to estimate depth of invasion.Materials and Methods: The data of patients with a T1-2 tongue cancer that had been treated surgically between 2014 and 2018 were retrospectively analysed. Measurements that had been taken by either MRI or ioUS were compared with those taken during histopathology.Results: A total of 83 patients with tongue cancer had undergone a pre-operative MRI and 107 had been studied through an ioUS. Tumour thickness measured by MRI (r = 0.72) and ioUS (r = 0.78) correlated significantly (p < 0.001) with histopathological depth of invasion (DOI). In tumours with a DOI of 0-10 mm, MRI has a mean absolute difference with histopathology of 3.1 mm (SD 3.2 mm) and ioUS of 1.6 mm (SD 1.3 mm). In tumours with a DOI greater than 10 mm, MRI has a mean absolute difference of 3.5 mm (SD 3.0 mm) and ioUS of 4.7 mm (SD 3.5 mm).Conclusion: Estimation of histopathological DOI in tongue cancers with DOI till 10 mm is very accurate through use of ioUS. ioUS tends to underestimate DOI in tumors exceeding 10 mm DOI. MRI tends to overestimate DOI in both thin and thick tumours. Since ultrasound measurements can be performed during surgery, ioUS could potentially guide the surgeon in the achievement of adequate resection margins. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
43. Staging and grading of oral squamous cell carcinoma: An update.
- Author
-
Almangush, Alhadi, Mäkitie, Antti A., Triantafyllou, Asterios, de Bree, Remco, Strojan, Primož, Rinaldo, Alessandra, Hernandez-Prera, Juan C., Suárez, Carlos, Kowalski, Luiz P., Ferlito, Alfio, and Leivo, Ilmo
- Subjects
- *
SQUAMOUS cell carcinoma , *TRANSFORMING growth factors , *DISEASE incidence , *ORAL cancer , *MOUTH tumors , *PROGNOSIS , *TUMOR classification , *TUMOR grading - Abstract
Oral squamous cell carcinoma (OSCC) is a common malignancy of the head and neck region. OSCC has a relatively low survival rate and the incidence of the disease is increasing in some geographic areas. Staging and grading of OSCC are established prerequisites for management, as they influence risk stratification and are the first step toward personalized treatment. The current AJCC/UICC TNM staging (8th edition, 2017) of OSCC has included significant modifications through the incorporation of depth of invasion in the T stage and extracapsular spread/extranodal extension in the N stage. Further modifications for AJCC 8 have been suggested. On the other hand, the World Health Organization (WHO) classification (4th edition, 2017) still endorses a simple, differentiation-based histopathologic grading system of OSCC (despite its low prognostic value) and ignores factors such as tumor growth pattern and dissociation, stromal reactions (desmoplasia, local immune response), and tumor-stroma ratio. The various controversies and possible developments of the current staging and grading criteria of OSCC are briefly discussed in this update together with possible applications of artificial intelligence in the context of screening and risk stratification. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.